EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Factors associated with rapid pediatric acute seizure emergency treatment: Quality Improvement in Time to Treat Status Epilepticus baseline cohort

Adam P Ostendorf iD, Gabrielle Brown-Mitchell, Tobias Loddenkemper iD, Lindsey A Morgan iD, Brian Appavu iD, Raquel Farias-Moeller iD, Dana Harrar iD, Craig Press iD, Janette Mailo iD, Nicholas S Abend iD, William D Gaillard iD, Shasha Bai iD und 5 weitere

Epilepsia · 2026

DOI: 10.1002/epi.70344 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Epilepsia, 2026. Verfasst von Adam P Ostendorf und 16 weiteren Autor:innen. Beteiligte Einrichtung: Nationwide Children's Hospital and Ohio State University, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Anticonvulsants, Benzodiazepines, Quality Improvement, Seizures. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Status epilepticus (SE) treatment is more effective when benzodiazepines (BZDs) are given soon after SE diagnosis. The Quality Improvement in Time to Treat Status Epilepticus (QuITT‐SE) trial is a multicenter, randomized, stepped‐wedge effectiveness‐implementation hybrid study aimed at improving time to SE treatment. We report the QuITT‐SE baseline cohort and test the hypothesis that acute seizure emergency episodes treated promptly differ in clinical and demographic features from those with delayed treatment.

Methods

Data were summarized from 371 consecutive acute seizures episodes treated with a BZD in the inpatient, non‐intensive care unit (ICU) setting from 207 individual patients across eight centers per the QuITT‐SE protocol. To test our hypothesis, we utilized a multivariable negative binomial mixed effects model with random intercepts to estimate the incidence rate ratios for variables of interest for time to BZD treatment.

Results

The median age was 7 years (IQR = 3–12). Nonelective ICU transfers occurred with 26% of episodes, including 13% within 6 h of the episode. The median time from seizure onset to BZD treatment was 6 min (IQR = 4–10), with 74% of all episodes and 63% of SE treated within 10 min. BZD administration was faster when nurses made the treatment decision, when the intranasal (IN) route was used, when the patient received prior rescue medication within 24 h, or with certain elective admission types. Seizures were shorter when BZD administration was faster or when treatment was with IN midazolam versus intravenous lorazepam (median = 8 min [IQR = 6–15] vs. 10 min [IQR = 7–17], p = .04). Patients were less likely to be transferred to the ICU if they received IN midazolam (odds ratio = .3, p = .007). Significance Delayed BZD administration occurs in one third of SE treatment. Prolonged seizures and ICU transfers are associated with modifiable risk factors. Baseline drivers of delayed acute seizure treatment may be addressed using the QuITT‐SE interventions, the study of which is currently ongoing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsBenzodiazepinesQuality ImprovementSeizuresStatus EpilepticusTime-to-TreatmentChildChild, PreschoolFemaleHumansMaleCohort StudiesLorazepamMidazolamTime FactorsTreatment Outcome

Stichwörter der Autor:innen

benzodiazepinepediatricseizurestatus epilepticustreatment delay

Substanzen

AnticonvulsantsBenzodiazepinesLorazepamMidazolam

Autor:innen und Institutionen

  • Nationwide Children's Hospital and Ohio State University, Columbus, Ohio, USA.
  • Boston Children's Hospital, Boston, Massachusetts, USA.
  • Seattle Children's Hospital and University of Washington, Seattle, Washington, USA.
  • Honor Health Neurology, Bob Bove Neuroscience Institute, Scottsdale, Arizona, USA.
  • Division of Pediatric Neurology, Department of Neurology, Children's Wisconsin and Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Center for Neuroscience and Behavioral Health, Children's National Hospital, George Washington University, Washington, District of Columbia, USA.

ORCID-Profile: Adam P Ostendorf, Tobias Loddenkemper, Lindsey A Morgan, Brian Appavu, Raquel Farias-Moeller, Dana Harrar, Craig Press, Janette Mailo, Nicholas S Abend, William D Gaillard, Shasha Bai, Mariah Eisner, Emily Kroshus, Kathryn Vannatta, Howard P Goodkin

Förderung

  • NINDS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Ostendorf, A. P., Brown-Mitchell, G., Loddenkemper, T., Morgan, L. A., Appavu, B., Farias-Moeller, R., Harrar, D., Press, C., Mailo, J., Abend, N. S., Gaillard, W. D., Bai, S., Eisner, M., Kroshus, E., Vannatta, K., Goodkin, H. P., & QuITT‐SE Study Group (2026). Factors associated with rapid pediatric acute seizure emergency treatment: Quality Improvement in Time to Treat Status Epilepticus baseline cohort. Epilepsia. https://doi.org/10.1002/epi.70344

Vancouver

Ostendorf AP, Brown-Mitchell G, Loddenkemper T, Morgan LA, Appavu B, Farias-Moeller R, et al. Factors associated with rapid pediatric acute seizure emergency treatment: Quality Improvement in Time to Treat Status Epilepticus baseline cohort. Epilepsia. 2026. doi:10.1002/epi.70344

BibTeX
@article{Ostendorf2026,
  author = {Ostendorf, Adam P and Brown-Mitchell, Gabrielle and Loddenkemper, Tobias and Morgan, Lindsey A and Appavu, Brian and Farias-Moeller, Raquel and Harrar, Dana and Press, Craig and Mailo, Janette and Abend, Nicholas S and Gaillard, William D and Bai, Shasha and Eisner, Mariah and Kroshus, Emily and Vannatta, Kathryn and Goodkin, Howard P and QuITT‐SE Study Group, QuITT‐SE Study Group},
  title = {Factors associated with rapid pediatric acute seizure emergency treatment: Quality Improvement in Time to Treat Status Epilepticus baseline cohort},
  journal = {Epilepsia},
  year = {2026},
  doi = {10.1002/epi.70344}
}
Kostenlos starten →